Artiva Biotherapeutics annual operating margin
2022
2023
2024
Artiva Biotherapeutics Operating Margin Growth & History (ARTV)
Artiva Biotherapeutics's operating margin was −26,805.58% for fiscal 2024.
View full Artiva Biotherapeutics company overviewArtiva Biotherapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −26,805.58% | −26712.42 pp |
| 2023 | 2023-12-31 | −93.16% | +1120.16 pp |
| 2022 | 2022-12-31 | −1,213.32% | — |
Artiva Biotherapeutics quarterly operating margin
Q2.23
Q3.23
Q1.24
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2024 | 2024-03-31 | −5,773.71% | — |
| Q3 2023 | 2023-09-30 | 40.56% | — |
| Q2 2023 | 2023-06-30 | −338.12% | — |
Artiva Biotherapeutics operating margin trends
Between the periods ended 2022-12-31 and 2024-12-31, Artiva Biotherapeutics's operating margin decreased from −1,213.32% to −26,805.58%, a change of −25592.25 percentage points. The latest reported quarter, Q1 2024, shows −5,773.71%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Artiva Biotherapeutics source filings ↗